Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-25 @ 9:20 PM
NCT ID: NCT03264456
Description: Given that fluciclovine is a FDA clinically approved radiotracer with almost no risk of serious adverse events and all cause mortality, the expected risk of these in this study is effectively 0.
Frequency Threshold: 0
Time Frame: Baseline through 8 week follow-up scan
Study: NCT03264456
Study Brief: Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
[18F] Fluciclovine PET/MRI \[18F\] Fluciclovine PET/MRI for pretreatment staging of high-risk prostate cancer \[18F\] Fluciclovine PET/MRI: \[18F\] fluciclovine PET/MRI \[18F\] fluciclovine: \[18F\] fluciclovine 0 None 0 14 0 14 View
Serious Events(If Any):
Other Events(If Any):